Illumina公司（纳斯达克代码：ILMN）今日在第43届J.P.摩根年度医疗大会上宣布了2024年第四季度和全年未经审计的初步财务结果，以及2025年的预期展望。大会将于2025年1月14日太平洋时间上午9:00（东部时间中午12:00）召开，网络直播可通过Illumina公司官方网站investor.illumina.com访问。 Illumina核心业务

• 2024年第四季度收入约为11亿美元，比2023年第四季度增长1％
• 2024年全年收入约为43.3亿美元，比2023年减少2％（按恒定汇率计算）
• 2024年第四季度GAAP营业利润率约为16.7%，全年为34.2%
• 2024年第四季度非GAAP营业利润率约为19.7%，全年为21.3%
• 2024年第四季度GAAP摊薄每股收益约为0.77-0.79美元，全年为5.65-5.67美元
• 2024年第四季度非GAAP摊薄每股收益约为0.91-0.93美元，全年为4.12-4.14美元
• 2024年运营现金流约为12.1亿美元，自由现金流（运营现金流减去资本支出）约为10.7亿美元
• 预计2025年按恒定汇率计算的收入增长为低个位数（报告收入在42.8亿至44亿美元之间），非GAAP营业利润率约为23%，非GAAP摊薄每股收益增长约10%

公司计划于2025年2月6日星期四市场收盘后公布完整的2024年第四季度和全年财务结果。本新闻稿中的未经审计结果为初步数据，尚需完成会计和年度审计程序，可能会有所调整。

以上内容来自Benzinga Earnings专栏，原文如下：

Illumina, Inc. (NASDAQ:ILMN) ("Illumina" or the "company") today announced unaudited preliminary financial results for the fourth quarter and fiscal year 2024 and preliminary outlook for fiscal year 2025 ahead of its presentation at the 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025 at 9:00 a.m. Pacific Time (12:00 p.m. Eastern Time). The webcast can be accessed through Illumina's website at investor.illumina.com.

Core Illumina

• Revenue of approximately $1.10 billion for Q4 2024, up 1% from Q4 2023
• Revenue of approximately $4.33 billion for 2024, down 2% from 2023 (and on a constant currency basis)
• GAAP operating margin of approximately 16.7% for Q4 2024 and 34.2% for 2024
• Non-GAAP operating margin of approximately 19.7% for Q4 2024 and 21.3% for 2024
• GAAP diluted EPS of approximately $0.77 - $0.79 for Q4 2024 and $5.65 - $5.67 for 2024
• Non-GAAP diluted EPS of approximately $0.91 - $0.93 for Q4 2024 and $4.12 - $4.14 for 2024
• Cash flow provided by operations of approximately $1.21 billion and free cash flow (cash flow provided by operations less capital expenditures) of approximately $1.07 billion for 2024
• For fiscal year 2025, expect constant currency revenue growth in the low single digits (reported revenue in the range of approximately $4.28 billion to $4.4 billion), non-GAAP operating margin of approximately 23%, and non-GAAP diluted EPS growth of approximately 10%

As previously announced, the company expects to report its full fourth quarter and fiscal year 2024 results following the close of market on Thursday, February 6, 2025. The unaudited results in this press release are preliminary and subject to the completion of accounting and annual audit procedures and are therefore subject to adjustment.